Treatment of multiple sclerosis by administration of interferon alpha and C-phycocyanin
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 7, 2012
Grant Date -
Nov 12, 2009
app pub date -
Oct 30, 2006
filing date -
Oct 28, 2005
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention consists of the combination of Interferon alpha and C-Phycocyanin (IFN-α/C-Phyco) for obtaining a pharmaceutical preparation for autoimmune disease, allergy and cancer treatments. The anti-inflammatory, immunomodulator, antioxidant, anti-viral, anti-proliferative and anti-tumoral effects, associated to the regulatory T cell inducer effect demonstrated in this invention is the rationale for the use of the IFN-α/C-Phyco combination in these diseases.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully